Our Portfolio

Current Ventures

Lumedi Inc.
Lumedi Inc.

Simple, Powerful, and Collaborative Solutions for Patient Support and Research.

View website

Mednet Inc.
Mednet Inc.

Mednet is an independent, Canadian-based global medical news reporting organization offering continuing medical education to health care professionals. Mednet specializes in balanced and objective summary reports based on accredited medical congresses and peer reviewed literature.

View website

Doceo Inc.
Doceo Inc.

Doceo.md is an information discovery platform that brings physicians together in a single community. It is the single source to find information that is relevant to clinical practice on the latest evidence, treatment trends, and the underlying drivers of health disparity.

View website

Otium Regulatory Inc.
Otium Regulatory Inc.

Otium is an online regulatory documentation platform that provides the required templates, documents, and the standards and guidelines to automate the creation of Clinical Study Protocols, Clinical Study Reports (CSRs), Investigator Brochures (IBs), and other related documents.

View website

Launchit DTx Inc.
Launchit DTx Inc.

Launchit DTx is changing the way we deal with disorders and pain. Not with more medicine, but through Prescription Digital Therapeutics.

View website

Webility Solutions Inc.
Webility Solutions Inc.

Webility is our custom software development firm with deep expertise in architecting and building enterprise healthcare software.

View website

Venture Pipeline

Rescue Bio Inc.
Rescue Bio Inc.

Problem

Acute inflammatory cytokine storms cause long-term problems for indications including systemic inflammatory responses such as Acute Respiratory Distress Syndrome (ARDS), Traumatic Brain Injury (TBI), Spinal Cord Injury (SCI) etc... There is no pharmacologic approach proven successful to date.

Solution

This patented therapeutic antibody and pathway blocks the bad inflammation while sparing the peripheral immune system to still fight infection.

Size of Market 

$1 billion for all systemic inflammatory indications including TBI, SCI, SIRS, ARDS, COPD, etc.

View website

Alertgy Inc.
Alertgy Inc.

Problem

Continuous glucose monitors (CGMs) are often invasive. The market leaders use interstitial fluid. These can lag and require constant attention and regular changes of the monitor.

Solution

Non-invasive, wearable, continuous glucose monitor you wear like a watch or bracelet.

Size of Market

Type 2 diabetes accounts for over 90% of the diabetic patient population = ~500,000 people worldwide. There is an estimated 80 million American with prediabetes (a perfect market for this technology). The sales of glucose meters last year was $4.5 billion. This technology would be disruptive to the current market.

View website

International Cardio Corporation
International Cardio Corporation

Problem

Invasive surgeries for the treatment and maintenance of the vascular system are expensive, time consuming, and dangerous.

Solution

A non-invasive High Intensity Frequency Ultrasound (HIFU) device that focusses and ablates certain cell types is a non-invasive treatment for many indications including Atrio-Ventricular (AV) Fistula, Peripheral Vascular Disease (PVD), and other diseases.

Size of Market 

First of many applications that has an unmet need and CPT code; AV Fistulas and maintenance cost $10,000 a case and redoing it costs $10,000 each time. Imaging and treating with the same device in clinic using the ICC product (with a fee code), is revolutionary.

View website

Endoventions Medical Inc.
Endoventions Medical Inc.

Problem

Current resectoscopes are expensive, reusable and fragile. They are time-intensive, reprocessing is inefficient, and prone to contamination. The field is unchanged for over 40 yrs. Current FDA guidance suggests a resurgence in disposable surgical devices.

Solution

The Endoventions Resectoscope is fully integrated, simple, disposable, no maintenance and has a low acquisition cost.

Size of Market 

Total treatment market = $14.22B:
Serviceable Addressable Market 325,000 procedures / year x $750 = $243.8M
Serviceable Obtainable Market (by Yr. 5) 24.5% market share of $243.8 mm = $57.3M